Newronika

company

About

Newronika restores brain and body functions with innovative technologies.

  • 11 - 50

Details

Last Funding Type
Grant
Industries
Bioinformatics,Biotechnology,Health Care,Hospital,Medical Device
Founded date
Jan 1, 2008
Number Of Employee
11 - 50
Operating Status
Active

Newronika restores brain and body functions with innovative technologies. We translate our deep knowledge on biosignal decoding into clinical practice, with the aim of improving treatments, health, and wellness. With our revolutionary brain devices, the patient receives the right stimulation at the right moment, thus becoming able to perform normal daily activities and improve quality of life.
Newronika is the spin-off company of two leading research institutions in Italy, the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Hospital and the University of Milan. ​
Newronika comprises a multidisciplinary team formed from Neuroscience research groups and involves scientists with expertise in neurophysiology, neurology, biomedical engineering, neuropsychology, bioinformatics, and biotechnologies.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
€10.10M
Newronika has raised a total of €10.10M in funding over 2 rounds. Their latest funding was raised on Dec 19, 2022 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 19, 2022 Grant 1 European Innovation Council Detail
Sep 25, 2019 Series A €8.40M 1 Detail
Jun 14, 2016 Series Unknown €1.70M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
2
Newronika is funded by 2 investors. European Innovation Council and F3F are the most recent investors.
Investor Name Lead Investor Funding Round
European Innovation Council Yes Grant
F3F Series A